Changes

no edit summary
Line 103: Line 103:  
|-
 
|-
 
| 4q12 || gain/amplification || PDGFRA (1,8) - ~50% of DIPG
 
| 4q12 || gain/amplification || PDGFRA (1,8) - ~50% of DIPG
 +
|-
 +
| 8q24.2 || gain/amplification || MYC/PVT1 (1,8) ~35%
 +
|-
 +
| 12q14.1/7q21.2/11q13.3 || gain/amplification || CDK4/6, CCND1-3 (1) ~20%
 +
|-
 +
| 2p25.1 || gain/amplification || ID2 (1) ~10%
 +
|-
 +
| 7q31.2 || gain/amplification || MET (1) ~7%
 
|}
 
|}
 
 
275

edits